_version_ 1784831244079464448
author Enssle, Julius Christoph
Moter, Alina
Campe, Julia
Gessner, Alec
Yu, Ika Weijia
Wolf, Sebastian
Steffen, Björn
Serve, Hubert
Bremm, Melanie
Huenecke, Sabine
Lohoff, Michael
Vehreschild, Maria
Rabenau, Holger F.
Widera, Marek
Ciesek, Sandra
Rieger, Michael A
Imkeller, Katharina
Metzler, Ivana von
Ullrich, Evelyn
author_facet Enssle, Julius Christoph
Moter, Alina
Campe, Julia
Gessner, Alec
Yu, Ika Weijia
Wolf, Sebastian
Steffen, Björn
Serve, Hubert
Bremm, Melanie
Huenecke, Sabine
Lohoff, Michael
Vehreschild, Maria
Rabenau, Holger F.
Widera, Marek
Ciesek, Sandra
Rieger, Michael A
Imkeller, Katharina
Metzler, Ivana von
Ullrich, Evelyn
author_sort Enssle, Julius Christoph
collection PubMed
description
format Online
Article
Text
id pubmed-9665226
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The American Society of Hematology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-96652262022-11-16 Portraying Immunity to Sars-Cov-2 after mRNA-Vaccination in Patients with Multiple Myeloma Enssle, Julius Christoph Moter, Alina Campe, Julia Gessner, Alec Yu, Ika Weijia Wolf, Sebastian Steffen, Björn Serve, Hubert Bremm, Melanie Huenecke, Sabine Lohoff, Michael Vehreschild, Maria Rabenau, Holger F. Widera, Marek Ciesek, Sandra Rieger, Michael A Imkeller, Katharina Metzler, Ivana von Ullrich, Evelyn Blood Oral Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665226/ http://dx.doi.org/10.1182/blood-2022-165871 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Oral Abstracts
Enssle, Julius Christoph
Moter, Alina
Campe, Julia
Gessner, Alec
Yu, Ika Weijia
Wolf, Sebastian
Steffen, Björn
Serve, Hubert
Bremm, Melanie
Huenecke, Sabine
Lohoff, Michael
Vehreschild, Maria
Rabenau, Holger F.
Widera, Marek
Ciesek, Sandra
Rieger, Michael A
Imkeller, Katharina
Metzler, Ivana von
Ullrich, Evelyn
Portraying Immunity to Sars-Cov-2 after mRNA-Vaccination in Patients with Multiple Myeloma
title Portraying Immunity to Sars-Cov-2 after mRNA-Vaccination in Patients with Multiple Myeloma
title_full Portraying Immunity to Sars-Cov-2 after mRNA-Vaccination in Patients with Multiple Myeloma
title_fullStr Portraying Immunity to Sars-Cov-2 after mRNA-Vaccination in Patients with Multiple Myeloma
title_full_unstemmed Portraying Immunity to Sars-Cov-2 after mRNA-Vaccination in Patients with Multiple Myeloma
title_short Portraying Immunity to Sars-Cov-2 after mRNA-Vaccination in Patients with Multiple Myeloma
title_sort portraying immunity to sars-cov-2 after mrna-vaccination in patients with multiple myeloma
topic Oral Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665226/
http://dx.doi.org/10.1182/blood-2022-165871
work_keys_str_mv AT ensslejuliuschristoph portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT moteralina portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT campejulia portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT gessneralec portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT yuikaweijia portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT wolfsebastian portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT steffenbjorn portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT servehubert portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT bremmmelanie portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT hueneckesabine portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT lohoffmichael portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT vehreschildmaria portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT rabenauholgerf portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT wideramarek portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT cieseksandra portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT riegermichaela portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT imkellerkatharina portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT metzlerivanavon portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma
AT ullrichevelyn portrayingimmunitytosarscov2aftermrnavaccinationinpatientswithmultiplemyeloma